Denmark’s benchmark OMX Copenhagen 20 index rose 1.29% on Tuesday, closing at a one-month high as gains in consumer goods and healthcare outweighed losses in industrials and shipping.
Advancing stocks outnumbered decliners by 66 to 50, with 20 equities unchanged. The index’s advance follows broader European equity strength, though regional energy and shipping names lagged.
Zealand Pharma A/S led gains with a 5.66% rise to 326.90, while Genmab added 3.98% to close at 2,196.00. Ørsted AS advanced 3.06% to 139.60 after late-session buying.
Decliners included Novozymes AS, which fell 1.84% to 448.00, and AP Moller - Maersk A/S, with both its A and B shares down 1.39% and 1.52%, respectively. The shipping giant’s B shares closed at 22,090.00, while A shares ended at 21,240.00.
Commodities ended mixed, with October WTI crude down 3.21% to $82.28 per barrel and November Brent crude down 3.15% to $87.69. December gold futures edged up 0.01% to $4,698.11 per troy ounce.
The Danish krone held steady against major peers, with USD/DKK and EUR/DKK largely unchanged at 6.41 and 7.48, respectively. The U.S. Dollar Index futures slipped 0.03% to 98.90.
